Abstract-The contributions of angiotensin II type 1 (AT 1 ) and type 2 (AT 2 ) receptors to the control of regional kidney blood flow were determined in pentobarbital-anesthetized rabbits. Intravenous candesartan (AT 1 antagonist; 10 g/kg plus 10 g · kg Ϫ1 · h
Ϫ1) reduced mean arterial pressure (12%) and increased total renal blood flow (29%) and cortical laser-Doppler flux (18%) but not medullary laser-Doppler flux. Neither intravenous PD123319 (AT 2 antagonist; 1 mg/kg plus 1 mg · kg Ϫ1 · h Ϫ1 ) nor saline vehicle significantly affected these variables, and the responses to candesartan plus PD123319 were indistinguishable from those of candesartan alone. In vehicle-treated rabbits, renal-arterial infusions of angiotensin II (1 to 25 ng · kg Ϫ1 · min Ϫ1 ) and angiotensin III (5 to 125 ng · kg Ϫ1 · min
Ϫ1) dose-dependently reduced renal blood flow (up to 51%) and cortical laser-Doppler flux (up to 50%) but did not significantly affect medullary laser-Doppler flux or arterial pressure. Angiotensin(1-7) (20 to 500 ng · kg Ϫ1 · min
Ϫ1) had similar effects but of lesser magnitude. CGP42112A (20 to 500 ng · kg Ϫ1 · min
Ϫ1) did not significantly affect these variables. After PD123319 administration, angiotensin II and angiotensin III dose-dependently increased medullary laser-Doppler flux (up to 84%), and reductions in renal blood flow in response to angiotensin II were enhanced. Candesartan abolished renal hemodynamic responses to the angiotensin peptides, even when given in combination with PD123319. We conclude that AT 2 receptor activation counteracts AT 1 -mediated vasoconstriction in the renal cortex but also counteracts AT 1 -mediated vasodilatation in vascular elements controlling medullary perfusion. These mechanisms might have an important effect on the control of medullary perfusion under conditions of activation of the renin-angiotensin system. Key Words: receptors, angiotensin Ⅲ kidney Ⅲ laser-Doppler flowmetry Ⅲ rabbits Ⅲ renal circulation T he medullary circulation contributes to the control of mean arterial pressure (MAP) and body fluid homeostasis. 1 However, the roles of angiotensin II type 1 (AT 1 ) and type 2 (AT 2 ) receptors in regulating regional kidney perfusion remain unclear. In rats and rabbits, infusions of angiotensin II reduce total renal blood flow (RBF) and cortical blood flow but have a lesser effect on medullary blood flow (MBF). [2][3][4][5] Angiotensin II can even increase MBF, especially when administered as a bolus. 6 -8 Nitric oxide synthase and/or cyclooxygenase blockade can enhance angiotensin II-induced reductions in MBF and abolish angiotensin II-induced increases in MBF, both of which are chiefly AT 1 mediated. 4,6 -12 However, the contributions of AT 2 receptors to these effects have received little attention, even though they are expressed in vessels that might contribute to MBF control (eg, afferent arterioles and vasa recta). 13 AT 2 -mediated counterregulatory vasodilatation can oppose AT 1 -mediated vasoconstriction. For example, in rat renalwrap hypertension, AT 2 re...